208. Atrial Fibrillation: Epidemiology, Health Equity, & The Double Paradox with Dr. Larry Jackson

Atrial fibrillation may reach pandemic proportions in the next 2-3 decades. Factors that drive this phenomenon have been studied in predominantly White populations, leading to a significant underrepresentation of certain racial/ethnic groups in atrial fibrillation epidemiological studies. Most atrial fibrillation epidemiology studies suggest that the non-Hispanic Black population has a…

Continue Reading208. Atrial Fibrillation: Epidemiology, Health Equity, & The Double Paradox with Dr. Larry Jackson

207. Lipids: REDUCE-IT Versus STRENGTH Trials – EPA in Clinical Practice with Dr. Peter Toth

CardioNerds Tommy Das (Program Director of the CardioNerds Academy and cardiology fellow at Cleveland Clinic), Rick Ferraro (cardiology fellow at the Johns Hopkins Hospital), and Dr. Aliza Hussain (cardiology fellow at Baylor College Medicine) take a deep dive on the REDUCE-IT trial with Dr. Peter Toth, director of preventive cardiology…

Continue Reading207. Lipids: REDUCE-IT Versus STRENGTH Trials – EPA in Clinical Practice with Dr. Peter Toth

206. Guidelines: 2021 ESC Cardiovascular Prevention – Question #12 with Dr. Laurence Sperling

The following question refers to Section 4.11 of the 2021 ESC CV Prevention Guidelines. The question is asked by Dr. Christian Faaborg-Andersen, answered first by UCSF resident Dr. Jessie Holtzman, and then by expert faculty Dr. Laurence Sperling. Dr. Laurence Sperling is the Katz Professor in Preventive Cardiology at the Emory University School of Medicine and…

Continue Reading206. Guidelines: 2021 ESC Cardiovascular Prevention – Question #12 with Dr. Laurence Sperling

205. Guidelines: 2021 ESC Cardiovascular Prevention – Question #11 with Dr. Eugenia Gianos

The following question refers to Section 6.1 of the 2021 ESC CV Prevention Guidelines. The question is asked by Dr. Christian Faaborg-Andersen, answered first by UCSD cardiology fellow Dr. Harpreet Bhatia, and then by expert faculty Dr. Eugenia Gianos. Dr. Gianos specializes in preventive cardiology, lipidology, cardiovascular imaging, and women’s heart disease; she is the director of…

Continue Reading205. Guidelines: 2021 ESC Cardiovascular Prevention – Question #11 with Dr. Eugenia Gianos

204. Guidelines: 2021 ESC Cardiovascular Prevention – Question #10 with Dr. Eileen Handberg

The following question refers to Section 4.6 of the  2021 ESC CV Prevention Guidelines. The question is asked by student Dr. Shivani Reddy, answered first by NP Carol Patrick, and then by expert faculty Dr. Eileen Handberg. Dr. Handberg is an Adult Nurse Practitioner, Professor of Medicine, and Director of the Cardiovascular…

Continue Reading204. Guidelines: 2021 ESC Cardiovascular Prevention – Question #10 with Dr. Eileen Handberg

203. Guidelines: 2021 ESC Cardiovascular Prevention – Question #9 with Dr. Noreen Nazir

The following question refers to Section 4.3 of the 2021 ESC CV Prevention Guidelines. The question is asked by Dr. Maryam Barkhordarian, answered first by pharmacy resident Dr. Anushka Tandon, and then by expert faculty Dr. Noreen Nazir. Dr. Noreen Nazir is Assistant Professor of Clinical Medicine at the University of Illinois at…

Continue Reading203. Guidelines: 2021 ESC Cardiovascular Prevention – Question #9 with Dr. Noreen Nazir

202. Guidelines: 2021 ESC Cardiovascular Prevention – Question #8 with Dr. Eugene Yang

This question refers to Sections 3.1 of the 2021 ESC CV Prevention Guidelines. The question is asked by CardioNerds Academy Intern, student Dr. Hirsh Elhence, answered first by internal medicine resident at Beaumont Hospital and soon to be Mayo Clinic cardiology fellow and Dr. Teodora Donisan and then by expert faculty Dr. Eugene…

Continue Reading202. Guidelines: 2021 ESC Cardiovascular Prevention – Question #8 with Dr. Eugene Yang

201. Guidelines: 2021 ESC Cardiovascular Prevention – Question #7 with Dr. Wesley Milks

The following question refers to Section 3.4 of the 2021 ESC CV Prevention Guidelines. The question is asked by student Dr. Adriana Mares, answered first by early career preventive cardiologist Dr. Dipika Gopal, and then by expert faculty Dr. Michael Wesley Milks. Dr. Milks is a staff cardiologist and assistant professor of…

Continue Reading201. Guidelines: 2021 ESC Cardiovascular Prevention – Question #7 with Dr. Wesley Milks

200. 2022 AHA/ACC/HFSA Guideline for The Management of Heart Failure – Hot Takes from The Journal of Cardiac Failure Family

CardioNerds (Amit Goyal, Daniel Ambinder) and special co-host Dr. Mark Belkin, join the Journal of Cardiac Failure Family to discuss the 2022 AHA/ACC/HFSA Guideline for The Management of Heart Failure. The JCF Editor-In-Chief Dr. Robert Mentz, Deputy Editor Dr. Anu Lala, and FIT editors -- Dr. Vanessa Bluemer, Dr. Ashish…

Continue Reading200. 2022 AHA/ACC/HFSA Guideline for The Management of Heart Failure – Hot Takes from The Journal of Cardiac Failure Family

199. Case Report: The Perfect Storm of Complications Post-Partum – Summa Health

CardioNerds (Amit Goyal and Daniel Ambinder) join Dr. Phoo Pwint Nandar (former FIT Ambassador), Dr. Deep Shah (current FIT Ambassador), and Dr. Sugat Wagle from the Summa Health Cardiology Department for an afternoon at Cuyahoga National Valley Park. We discuss a case of a post-partum woman who presented with ventricular fibrillation arrest due…

Continue Reading199. Case Report: The Perfect Storm of Complications Post-Partum – Summa Health

End of content

No more pages to load